Psychopathological characteristics in patients with arginine vasopressin deficiency (central diabetes insipidus) and primary polydipsia compared to healthy controls.

Journal: European journal of endocrinology

Volume: 

Issue: 

Year of Publication: 

Affiliated Institutions:  Department of Endocrinology, Diabetology and Metabolism, University Hospital Basel, Basel, Switzerland. Department of Endocrinology, Diabetology and Clinical Nutrition, University Hospital Zurich and University of Zurich. Department of Internal Medicine, Medical School of the Federal University of Minas Gerais, Belo Horizonte, MG, Brazil. Department of Clinical Research, University of Basel, Basel, Switzerland.

Abstract summary 

Distinguishing arginine vasopressin deficiency (AVP-D; central diabetes insipidus) from primary polydipsia (PP), commonly referred to as psychogenic polydipsia, is challenging. Psychopathologic findings, commonly used for PP diagnosis in clinical practice, are rarely evaluated in AVP-D patients, and no comparative data between the two conditions currently exist.Data from two studies involving 82 participants (39 AVP-D, 28 PP, and 15 healthy controls [HC]).Psychological evaluations were conducted using standardized questionnaires measuring anxiety (State-Trait Anxiety-Inventory [STAI]), alexithymia (Toronto Alexithymia-Scale [TAS]), depressive symptoms (Beck's Depression Inventory-II [BDI-II], and overall mental health (Short-Form-36 Health-Survey [SF-36]). Higher STAI, TAS, and BDI-II scores suggest elevated anxiety, alexithymia, and depression, while higher SF-36 scores signify better overall mental health.Compared to HC, patients with AVP-D and PP showed higher levels of anxiety (HC 28 points [24-31] vs AVP-D 36 points [31-45]; vs PP 38 points [33-46], p<0.01), alexithymia (HC 30 points [29-37] vs AVP-D 43 points [35-54]; vs PP 46 points [37-55], p<0.01), and depression (HC 1 point [0-2] vs AVP-D 7 points [4-14]; vs PP 7 points [3-13], p<0.01). Levels of anxiety, alexithymia, and depression showed no difference between both patient groups (p=0.58, p=0.90, p=0.50, respectively). Compared to HC, patients with AVP-D and PP reported similarly reduced self-reported overall mental health scores (HC 84 [68-88] vs AVP-D 60 [52-80], p=0.05; vs PP 60 [47-74], p<0.01).This study reveals heightened anxiety, alexithymia, depression, and diminished overall mental health in patients with AVP-D and PP. The results emphasize the need for careful interpretation of psychopathological characteristics to differentiate between AVP-D and PP.

Authors & Co-authors:  Atila Beck Refardt Erlic Drummond Sailer Liechti Rocha Beuschlein Winzeler Christ-Crain

Study Outcome 

Source Link: Visit source

Statistics
Citations : 
Authors :  11
Identifiers
Doi : lvae040
SSN : 1479-683X
Study Population
Male,Female
Mesh Terms
Other Terms
AVP-D;alexithymia;anxiety;depression;habitual polydipsia;hypopituitarism;mental health;posterior pituitary;psychogenic polydipsia;psychopathology;quality of life
Study Design
Study Approach
Country of Study
Publication Country
England